Greer Sponsors Landmark Study Analyzing The Benefits And Cost Effectiveness Of Allergy Immunotherapy Among Children With Allergic Rhinitis

Greer, a leading developer and provider of allergy immunotherapy products and services, provided a grant to BioMedEcon to conduct a retrospective study analyzing the use of allergy immunotherapy via subcutaneous injections in children with allergic rhinitis. The study analyzed Medicaid records of 520 low-income Florida children with documented allergies.

More: continued here

Filed under: Allergies on February 7th, 2008